Why India rejected a patent application for shorter drug-resistant TB treatment | Explained

The Hindu: Latest News today from India and the World, Breaking news, Top Headlines and Trending News Videos. ·
Health Medicine India
India

The decision could open the door to greater generic competition, but its impact on treatment costs will depend on drug availability, pricing, and access to care

Read original article on The Hindu: Latest News today from India and the World, Breaking news, Top Headlines and Trending News Videos. →